Results 61 to 70 of about 463 (147)

High-risk subtypes of chronic lymphocytic leukemia are detectable as early as 16 years prior to diagnosis.

open access: yesBlood, 2022
Kolijn PM   +23 more
europepmc   +1 more source

Convalescent plasma improves overall survival in patients with B-cell lymphoid malignancy and COVID-19: a longitudinal cohort and propensity score analysis. [PDF]

open access: yesLeukemia, 2022
Hueso T   +20 more
europepmc   +1 more source

Lifetime Hormonal Exposure and Risk of Lung Cancer in Women: Results From a French Population-Based Case-Control Study (The WELCA Study). [PDF]

open access: yesCancer Med
Gueye Y   +11 more
europepmc   +1 more source

Mediating role of the body mass index in the prospective association between a healthy diet and evolution of asthma symptoms in elderly women. [PDF]

open access: yesJAR Life
Ait-Hadad W   +10 more
europepmc   +1 more source

Etude des facteurs predictifs d'evenements apres syncopes ou pre syncopes et exploration electrophysiologique negative

open access: yes, 2003
La prise en charge des patients avec syncope ou etat pre-syncopal dont le bilan initial est negatif represente un probleme clinique important. Chez ces patients, le role de l'exploration electrophysiologique (EEP) dans la stratification pronostique est ...
GULIAN, Jean-Luc   +2 more
core  

Lymphoma patients treated with anti-CD20 and chemotherapy display disconnected T and B cell responses to COVID-19 vaccine. [PDF]

open access: yesFront Immunol
Lamure S   +13 more
europepmc   +1 more source

Çocukluk çağı lenfomalarının retrospektif değerlendirmesi

open access: yes, 2005
ÖZET Amaç: Bu çalışmada çocukluk çağı lenfoma vakalarının klinik ve demografik özellikleriyle beraber tedavilerinin retrospektif olarak incelenmesi ve sağ kalım üzerine etkilerinin değerlendirilmesi amaçlandı.
AHMET ÖZCAN
core  

[Genetic hypothesis involving Haglund's syndrome and its association with ankylosing spondylitis: case report]. [PDF]

open access: yesPan Afr Med J, 2021
Douma H   +7 more
europepmc   +1 more source

Home - About - Disclaimer - Privacy